GB1520208A - Tumour detection - Google Patents

Tumour detection

Info

Publication number
GB1520208A
GB1520208A GB22283/77A GB2228377A GB1520208A GB 1520208 A GB1520208 A GB 1520208A GB 22283/77 A GB22283/77 A GB 22283/77A GB 2228377 A GB2228377 A GB 2228377A GB 1520208 A GB1520208 A GB 1520208A
Authority
GB
United Kingdom
Prior art keywords
cancer
tumour
tubes
detected
extracts
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB22283/77A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of GB1520208A publication Critical patent/GB1520208A/en
Expired legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/5743—Specifically defined cancers of skin, e.g. melanoma
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57411—Specifically defined cancers of cervix
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57423—Specifically defined cancers of lung
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57438—Specifically defined cancers of liver, pancreas or kidney
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57449—Specifically defined cancers of ovaries

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Food Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
GB22283/77A 1976-05-27 1977-05-26 Tumour detection Expired GB1520208A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US69045476A 1976-05-27 1976-05-27

Publications (1)

Publication Number Publication Date
GB1520208A true GB1520208A (en) 1978-08-02

Family

ID=24772522

Family Applications (1)

Application Number Title Priority Date Filing Date
GB22283/77A Expired GB1520208A (en) 1976-05-27 1977-05-26 Tumour detection

Country Status (18)

Country Link
JP (1) JPS52145517A (de)
AT (1) AT357690B (de)
AU (1) AU506539B2 (de)
BE (1) BE855063A (de)
DE (1) DE2724114A1 (de)
DK (1) DK233277A (de)
ES (1) ES459164A1 (de)
FI (1) FI771646A (de)
FR (1) FR2352533A1 (de)
GB (1) GB1520208A (de)
IE (1) IE45284B1 (de)
IL (1) IL52133A0 (de)
LU (1) LU77413A1 (de)
NL (1) NL7705873A (de)
NO (1) NO771860L (de)
NZ (1) NZ184159A (de)
SE (1) SE7706203L (de)
ZA (1) ZA773026B (de)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3999944A (en) * 1975-02-28 1976-12-28 Hoffmann-La Roche Inc. Detection of breast cancer
US4043757A (en) * 1975-05-20 1977-08-23 Ortho Pharmaceutical Corporation Method for detection of human mammary carcinoma

Also Published As

Publication number Publication date
ATA376977A (de) 1979-12-15
ES459164A1 (es) 1978-04-16
AU2534177A (en) 1978-11-23
NO771860L (no) 1977-11-29
NZ184159A (en) 1979-03-28
IE45284L (en) 1977-11-27
FI771646A (de) 1977-11-28
IL52133A0 (en) 1977-07-31
DE2724114A1 (de) 1977-12-15
AU506539B2 (en) 1980-01-10
LU77413A1 (de) 1978-06-26
JPS52145517A (en) 1977-12-03
FR2352533B1 (de) 1980-06-13
ZA773026B (en) 1978-04-26
AT357690B (de) 1980-07-25
NL7705873A (nl) 1977-11-29
BE855063A (fr) 1977-11-28
DK233277A (da) 1977-11-28
FR2352533A1 (fr) 1977-12-23
SE7706203L (sv) 1977-11-28
IE45284B1 (en) 1982-07-28

Similar Documents

Publication Publication Date Title
IT7819258A0 (it) Procedimento e dispositivo per il rilevamento di microrganismi, per esempio in liquidi corporei
JPS57132878A (en) Sonde for measuring volatile component of culture medium of fermentation industry
GB2049949B (en) Electromagnetic flowmeters and methods for measuring flow
GB1358828A (en) Process for detecting the presence of human carcinoembryonic antigen material or component a or b thereof in blood
GB1290642A (de)
ATE11930T1 (de) In vitro verfahren zum bestimmen von krebs im saeugergewebe.
GB1533835A (en) Sputum analysis method
GB1520208A (en) Tumour detection
JPS51143386A (en) Magnetic flaw detector with water spray
ES456306A1 (es) Procedimiento para la identificacion selectiva del organismo"e. coli".
JPS5332186A (en) Microorganism culture medium containing fluorescent growth indicator
GB1263754A (en) Process for the continuous rapid measurement of the content of biodegradable constituents of a fluid
JPS5236914A (en) Magnetic recording and reproducing device
JPS5342002A (en) Method for inspection of magnetic recording medium
GB686289A (en) Improvements in or relating to record cards, tapes or the like supports, and the recording of magnetic marks on such supports
DK30780A (da) Nye antiobiotisk virksomme forbindelser med rifamycingrundstruktur fermentativ fremstilling deraf samt anvendelse deraf
JPS51149059A (en) Respiration flow velocity measuring method and transducer
GB1503851A (en) Process for preparing cephalosporin
JPS5358211A (en) Magnetic recording and reproduction position determining system of magleisurecard
GB1252792A (de)
JPS5221739A (en) Magnetic media discriminating method
JPS5347635A (en) Guide system for moving body
JPS5391764A (en) Moving direction detector
GB1514091A (en) Process for preserving pharmaceutical compositions and the compositions prepared thereby
JPS5387759A (en) Ultrasonic flow meter

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]
PCNP Patent ceased through non-payment of renewal fee